Mutant p53 and MDM2 in Cancer
Springer Netherlands
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Chapter title |
Mdm2 and MdmX Involvement in Human Cancer.
|
|---|---|
| Chapter number | 15 |
| Book title |
Mutant p53 and MDM2 in Cancer
|
| Published in |
Sub cellular biochemistry, September 2014
|
| DOI | 10.1007/978-94-017-9211-0_15 |
| Pubmed ID | |
| Book ISBNs |
978-9-40-179210-3, 978-9-40-179211-0
|
| Authors |
Berberich SJ, Steven J. Berberich, Berberich, Steven J. |
| Abstract |
Discovered in 1987 and 1997 respectively, Mdm2 and MdmX represent two critical cellular regulators of the p53 tumor suppressor. This chapter reviews each from initial discovery to our current understanding of their deregulation in human cancer with a focus on how each regulator impacts p53 function. While p53 independent activities of Mdm2 and MdmX are noted the reader is directed to other reviews on this topic. The chapter concludes with an examination of the various mechanisms of Mdm-deregulation and an assessment of the current therapeutic approaches to target Mdm2 and MdmX overexpression. |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 2 | 20% |
| Student > Ph. D. Student | 2 | 20% |
| Student > Master | 1 | 10% |
| Researcher | 1 | 10% |
| Student > Postgraduate | 1 | 10% |
| Other | 0 | 0% |
| Unknown | 3 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 20% |
| Biochemistry, Genetics and Molecular Biology | 2 | 20% |
| Agricultural and Biological Sciences | 2 | 20% |
| Chemistry | 1 | 10% |
| Unknown | 3 | 30% |